BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CXCL2
,
Apoptosis
,
Pseudomonas infection
,
Stem cell
,
Biofuel
,
Prozac
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DPYD
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the expla…
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping.
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase.
Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Sa…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Identifying Novel Variants in the DPYD Gene in Patients of Non-Western Descent
Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluorop…
Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmac…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ